
Extend Podcast with Darshan Shah, MD 136. Dr. Goodenowe: Plasmalogens and the Hidden Science of Longevity
Feb 5, 2026
Dr. Dayan Goodenowe, a neuroscientist and chemist who invented advanced metabolomics tools, explains the hidden role of plasmalogens in cellular membrane health. He discusses how falling plasmalogen levels predict dementia, cancer recurrence, and mortality years before symptoms. The conversation covers restoring membranes with precursors, tracking brain regrowth with advanced MRI, and prioritizing mental acuity, mobility, and mood.
AI Snips
Chapters
Transcript
Episode notes
Disease Starts With Measurable Prodromes
- Longitudinal blood measurements showed low plasmalogens precede dementia and predict mortality far before symptoms appear.
- Prodromal biochemical shifts mean we lose health gradually rather than suddenly contracting disease.
Measure And Restore Health Early
- Measure biochemical deviation early and restore missing molecules before symptoms arise to maintain resilience.
- Treat health like preventive maintenance: top off deficiencies rather than wait for failure.
Supplementation Shows Causation In Models
- Plasmalogen precursors restored membrane integrity in animal models and prevented toxin-induced Parkinsonism and demyelination.
- Supplementing plasmalogens can be causal therapy, not just a biomarker.
